The Latest of UWO's Tech Transfer Office- Page 14 of 15

Startup Hiring! LifeLike BioTissue Inc.

on November 6, 2013

Position Description We are a growing Life Science company who manufactures realistic surgical skills training simulators and is looking to hire a dynamic, extroverted, sales oriented individual with a background in science or social sciences or business to take on a Sales and Customer Service Representative position in London, ON. The Individual must have ability and curiosity to learn anatomy and surgical procedures terminology, have very strong written and oral communications skills, and strong work ethic and ability/desire to work from the office and/or home setting. The candidate must be a recent graduate of a science or social science program at the university or college level.

Western Innovation Fund (WIF) Competition

on September 26, 2013

The Western Innovation Fund awards are supported by the Office of the Vice-President (Research) are intended to fund projects that will advance innovative research results towards application and commercialization. This competition is for one-time projects based on existing research initiatives. Applicants can only receive one grant per type of project or technology. WORLDiscoveries® personnel are available for consultation on issues related to intellectual property and commercialization.

Research Park Plan Looks to Fuel Collaboration

on September 19, 2013

Paul Paolatto has seen the shift. Now, he wants Western and the City of London to take advantage of it.
Once viewed as too institutional by industry leaders, university-led research parks have evolved into “marquee addresses” for those seeking a deeper collaboration between industry and the academe.

“It gives them preferred access to great knowledge and high-performance people – not only faculty, but students as well,” said the Western Research Parks executive director. “They are starting to appreciate that.”

London Find Makes Light Work of Cleaning Tasks

on September 17, 2013

A London firm is making cleaning as easy as turning on a light.

Sunwash Technologies has developed an additive for plastic coatings or paints to create a self-cleaning polymer surface for counters and floors.

The self-cleaning surface helps break down biological pollutants, oils, natural toxins, pesticides and other organic material when exposed to oxygen and light.

The material is being tested in food-processing plants in the London area.

“We think there’s a huge potential. Even though we have not marketed the product we have already had companies contact us,” said Dan Jenken, a Sunwash co-founder.

Jenken said the coating doesn’t replace normal cleaning but makes it easier and more effective. The self-cleaning surfaces are more environmentally friendly, reducing the need for harsh, toxic cleaning products.

The coatings don’t degrade or wear out after years of use. The stronger the light, the more effective the cleaning process.

Sunwash was born out of a public-private partnership.

A Better Mousetrap To Help Skin Cancer Patients

on September 11, 2013

There is a moment when a surgeon is removing a skin cancer, delicately cutting away as little tissue as possible, when he or she needs to know if the procedure got the entire tumour.

Any residual cancerous tissue must be removed, but the object of the Mohs surgical procedure is to make as small an excision as possible, leaving little or no evidence there was ever a cancer or an operation to remove it. This is especially important if the cancer is on the face and requires plastic reconstruction.

A patent’s not a patent until it issues

on September 5, 2013

A patent is a set of rights granted by a country or state to exclude others from making, using or selling your invention for specified period of time – usually 20 years from the date of filing of the initial application. This monopoly is the quid pro quo to the inventor for sharing a complete description of the invention with the public. The aim of the patent system is to benefit society and foster innovation by providing future inventors with the benefit of your knowledge. The origins of modern patent rights trace their history back to the 14th and 15th centuries in Italy and England, although as far back as 3rd century in ancient Greece, records show that exclusive rights were granted to creators of unique culinary dishes for fixed periods.

Invitations to register published patents may be spelt S C A M

on September 5, 2013

If you are listed as an inventor on a patent application, you may have received one or more invitations to register your patent application in an international database on payment of a fee. The invitations may well appear legitimate and will likely come from companies with names such as “Worldwide Database of Patents”, “Central Patent & Trademark Database” or “World IP Database”. However, these have no connection to the body that actually manages prosecution of international patent applications, the World Intellectual Property Organization (WIPO), and such registrations are not part of the prosecution of your patent applications.

HIV vaccine produces no adverse effects in trials

on September 4, 2013

Phase I Clinical Trial (SAV CT 01) of the first and only preventative HIV vaccine based on a genetically modified killed whole virus (SAV001-H) has been successfully completed with no adverse effects in all patients, Western and Sumagen Canada Inc. announced today.

Developed by Dr. Chil-Yong Kang and his team at the Schulich School of Medicine & Dentistry, with the support of Sumagen Canada, the vaccine (SAV001-H) holds tremendous promise for success in the final phases of clinical testing now that the first hurdle has been accomplished. It is the only HIV vaccine developed in Canada currently in clinical trial, and one of only a few in the world.

Technology teamup targets liver cancer

on August 13, 2013

Western has teamed up with the Centre for Imaging Technology Commercialization (CIMTEC) and Claron Technology Inc. in developing hardware and original software modules in the treatment of liver cancer in developing countries.

Combined into an image-guided oncology therapy system, this collaborative project has the potential to impact liver cancer treatment in India, North Asia and part of Europe, where access to CT (computed tomography) and MR (magnetic resonance) scanners is extremely limited, said Western professor and CIMTEC director Aaron Fenster.

Cineplex Offers to Acquire EK3 Technologies Inc.

on July 17, 2013

Cineplex has announced its offer to purchase EK3 Technologies, a digital merchandising provider in London with operations in Canada, the United States and other countries.

The initial offer is approximately $40 million, in addition to a reverse earn-out payment which could push the total purchase price up to $78 million.

EK3 will be renamed and operate as Cineplex Digital Networks (CDN) and will continue to be led by EK3 President and CEO, Nick Prigioniero.

News

Startup Hiring! LifeLike BioTissue Inc.

Western Innovation Fund (WIF) Competition

Research Park Plan Looks to Fuel Collaboration

London Find Makes Light Work of Cleaning Tasks

A patent’s not a patent until it issues

Invitations to register published patents may be spelt S C A M

HIV vaccine produces no adverse effects in trials

Technology teamup targets liver cancer

Cineplex Offers to Acquire EK3 Technologies Inc.

Annual Reports

News Categories

Archives

A leader in turning research and innovations into profitable consumer-ready products...

WORLDiscoveries